Summer is here!
__________________
Please welcome our newest member:
Kurt Burgess
Business Development/Corporate Services
Jon E. Block Ph.D. Incorporated
San Francisco, California
Please welcome our Montana Bioscience
Alliance Intern:
Shaun Hoover
Shaun is a senior at Montana State University-
Billings. He will graduate in December with a
Bachelor of Science in Business Administration with
an emphasis in Marketing and Management. He has
already mastered the website and the newsletter for
the Montana BioScience Alliance.
Also, don't forget to REGISTER HERE for the Annual
Meeting on July 16th and 17th!
|
|
Member News |
 |
Genectar to Occupy New Biotech
Lab
Genectar will occupy a new biotechnology laboratory
in Columbia Falls. Commercial grade utilities were
placed on the 9.5 acre building site. A roof will be
completed in June 2009.
Genectar President Thomas M. Brown
presented "Pigmentation Genetics and the Eye of a
Moth" to Flathead Community College Seminar Series
on April 23, 2009 and will present "A candidate golden
gene (slc24a5) from a Lepidopteran, Bombyx mori by
Comparative Genomics" to the Third Arthropod
Genomics Conference in Kansas City from June 11-
13, 2009.
________________________
Summit Corporate Services and
Mederi Therapeutics Finalize Multi-Year Outsourcing
Agreement
BOZEMAN, MONTANA (June 1, 2009) - Summit
Corporate Services, Inc., a leading provider of
customer service and supply chain solutions for the
medical device and pharmaceutical industries, and
Mederi Therapeutics Inc., a medical device company
whose first two products deliver proprietary minimally
invasive treatments for GERD (gastroesophageal
reflux disease) and FI (fecal incontinence), have
finalized an agreement for Summit to provide
customer service, order processing & fulfillment,
product support, inventory management, distribution,
invoicing, collections and logistical support for
Mederi's Stretta® and Secca® product lines.
Secca® is an innovative treatment option for patients
suffering from FI. The Secca® procedure involves no
implants, incisions or stitches and is performed in an
outpatient setting. Stretta® is a minimally invasive
treatment for patients suffering from GERD. Studies
have shown that Stretta® produced significant
improvement in GERD symptom scores for heartburn,
patient satisfaction and quality of life while eliminating
or decreasing the need for medication. Similar
studies have shown sustained benefits over 4 years
of follow up. Additional information on the Secca® and
Stretta® treatments is available online at
www.mederitherapeutics.com.
Summit Corporate Services specializes in providing
customized outsourcing solutions to medical
companies who market highly complex products.
Summit's extensive service options include: customer
service, product support, order processing and
fulfillment, inventory management, distribution,
logistics, billing, collections, quality assurance and
subject recruitment. Summit's outsourcing solutions
are applicable to all industries and have helped
numerous clients, including Stryker Spine, Cardo
Medical, Bone Support, and Wound Care
Technologies control costs and improve efficiencies.
Summit Corporate Services is headquartered in
Bozeman, Montana. Additional information is available
at
www.summit
corporate.com.
________________________
Billings Clinic Research Center
Billings Clinic Research Center was chosen one out
of six sites nationwide for a Phase I investigational
oral drug for multiple sclerosis. This new class of
drugs is designed to block T and B cell migration from
the thymus and lymph nodes, decreasing circulating
blood lymphocyte counts, suppressing one part of the
immune function.

|
|
Universities |
 |
Cover of Journal shows cell infected by virus first
viewed by MSU scientists
By MELYNDA HARRISON
The June cover of the Journal of Virology features a
photograph of the unusual effects on a cell infected by
a virus. Montana State University researchers were the
first to view the virus, which they collected from a
boiling, acidic spring in Yellowstone.
The article linked with the cover photograph describes
the researchers' findings about the life cycle of the
virus Sulfolobus turreted icosahedral virus (STIV). No
one has seen STIV replicate within a host cell prior to
the work done by MSU scientists.
"What is really surprising is how the virus gets out of
the infected cell," said MSU virologist Mark
Young.
STIV forms a pyramid-like projection on the surface of
the cell.
"It looks just like the glass pyramid in front of the
Louvre," Young said.
Understanding how particular viruses assemble and
replicate often leads to new uses for the virus. For
example, laboratories run by Young and chemist
Trevor Douglas at MSU have demonstrated that
viruses can be used for beneficial purposes ranging
from creating smart drug delivery and imaging
systems to making viruses act as nano-containers for
making high performance magnetic materials for the
computer industry.
Susan Brumfield, Vincent Ruigrok, Peter Suci,
Douglas and Young of MSU and Alice Ortmann of the
University of South Alabama, Mobile, investigated the
effects of the virus on its host cell.
The pyramid-like projections have not been
documented in any other host-virus system, according
to the paper's authors. The structures are thought to
be at sites where the virus' progeny are released from
the cell.
The STIV virus was collected from Yellowstone
National Park and brought back to a laboratory at
MSU. The extreme environment that STIV lives in had
to be replicated in order to keep the virus alive for
study.
"Essentially we had to recreate Yellowstone in the
lab," said Young.
The virus and its host cells continued to grow in an
acid solution that mimics the water of Yellowstone hot
springs and in specialized incubators that kept the
virus at a toasty 176 degrees Fahrenheit. Then, the
scientists were able to view the virus within its host
using a high power electron microscope.
"We can look at the virus inside the cell for the first
time," said principle author, Brumfield. "We could
watch the construction of the virus in the cell and see
how it released itself from the host cell."
"It's really an engineering feat," Young added. "It's kind
of like building a house, and we saw it do that inside
the cell for the first time."
"We'll continue to look in Yellowstone, and places like
Yellowstone around the world," said
Young. "Understanding viruses is fundamental work."
The Journal of Virology is one of the top three (of 25)
virology journals according to the Institute for Scientific
Information.
Contact Mark Young at (406) 994-5158 or
myoung@montana.edu
____________________________
UM Offers Cancer Biology Class This Summer
UM will offer a new, five-week introductory course on
cancer this summer that is open to students in all
majors. Introduction to Cancer Biology will provide an
overview for undergraduate students interested in an
accessible course on cancer and its treatment and
prevention.
The three-credit course has no prerequisites and
satisfies the lecture portion of the natural science
general education requirement. It will be held from 1
to 3 p.m. Monday through Thursday during the second
summer session, June 29-July 30, in air-conditioned
Skaggs Building Room 117.
The class will be taught by course coordinator Mark
Pershouse. Additional faculty members will teach
sections on cancer epidemiology, familial and non-
familial cancers, and the fundamentals of cancer
treatment. The final lectures on the latest options in
cancer treatment will be given by Dr. Patrick Beatty,
president of the Montana Cancer Institute, a UM-St.
Patrick Hospital and Health Sciences Center
collaboration.
To register, visit
Cyberbear.
The course registration number is 51424. For more
information, call Pershouse at 406-243-4769 or e-
mail mark.pershouse@umontana.edu

|
|
Montana News |
 |
Congratulations to the Montana
Cancer Center Staff!
The Montana Cancer Center in Missoula was the
recipient of the 2008 Commission on Cancer
Outstanding Achievement Award. This achievement is
indicative of the outstanding efforts of the Montana
Cancer Center Staff and they're commitment to
provide patient with quality cancer care.
____________________________
Reporter's Notebook: Miles City
Scientist's Work
Still Paying Off
By DIANE COCHRAN - Billings Gazette
What would Dr. Maurice Hilleman do?
That question has almost certainly crossed the minds
lately of people who know of Hilleman, a skilled
scientist who invented some 40 vaccines, including
eight of the 14 childhood vaccines commonly used in
the United States.
How would Hilleman, who died in 2005 at age 85,
react to the H1N1 strain of influenza that surfaced last
month in Mexico?
Lab skills
Could he have put his awesome laboratory skills to
work on a vaccine for the new bug, also called the
swine flu, the way he did in 1957 when he logged nine
14-hour days in a row to identify the Hong Kong flu?
That particular influenza ended up killing 69,000
Americans, but another 40 million got vaccines based
on Hilleman's work.
Despite his immeasurable influence on public health -
news accounts published at the time of his death put
into the millions the number of lives his work has
saved - Hilleman is relatively unknown.
"Among scientists, he is legend," Dr. Anthony Fauci,
director of the National Institute of Allergy and
Infectious Diseases, told the Washington Post in
2005. "But to the general public, he is the world's best-
kept secret."
Even Montanans, who take pride in keeping tabs on
locals who splash big in the wider world, don't seem
to know about Hilleman.
Yep. He was one of us.
Maurice Ralph Hilleman was born Aug. 30, 1919, in
Miles City. His mother and twin sister died during the
birth, and he and his older siblings were raised on a
family member's farm.
CLICK HERE for the
complete story on the first person to be indcuted into
the Montana Bioscience Hall of Fame.
____________________________
Entrepreneurship Center receives
grant
By JOHN CRAMER - Ravalli Republic
Funding for the proposed the Ravalli
Entrepreneurship Center continued to solidify
Thursday with the awarding of a $200,000 federal
grant toward construction of a wastewater lift
station.
The Montana Department of Commerce on Thursday
announced the Community Development Block Grant-
Economic Development funds have been approved for
the city of Hamilton.
The city will provide the money to the Ravalli County
Economic Development Authority for construction of a
sewerage lift station for the REC.
The city will own the lift station, which is a key part of
infrastructure needed for economic development.
The lift station also will provide sewer services for a
senior housing cooperative proposed by the Ravalli
County Council on Aging, as well as for new housing
in the area.
The REC, which has been planned for more than a
decade, will be an incubator that offers laboratories
and office space to promote small start-up technology
businesses.
The county's growing bio-technology and research
industry already employs hundreds of workers at
GlaxoSmithKline and Rocky Mountain Laboratories,
which might open branches in the REC.
The REC is to be built on Old Corvallis Road on four
acres of the Council on Aging's property.
Ground breaking began this spring and construction
will be completed later this year.
The picture below:(From
left) Ravalli County Commissioner Kathleen Driscoll,
Inga Rudbach, Ravalli County Economic Development
Authority Chairman Monte Drake and Hamilton Mayor
Jerry Steele wielded golden shovels at the ground
breaking.
The facility will have three full-time equivalent jobs,
while the Council on Aging and Senior Housing
Cooperative will create five full-time positions.
"Many partners are contributing significantly to this
project," Anthony Preite, state commerce department
director, said in a statement. "That sense of teamwork
and cooperation to leverage sources for a common
cause really gets work done."
The REC project will cost $3.2 million with $350,000
of that going to the lift station construction.
The REC also will be funded by a $1.6 million grant
from a U.S. Economic Development Administration.
The Ravalli County Council on Aging and the
Bessenyey family will donate land valued at
$1,021,440.
The REC's other funding includes a loan from Ravalli
County Bank for $65,000, a loan for $135,000 from
Economic Development Authority's Revolving Loan
Fund, $59,000 in equity from the authority, a loan from
Montana Technology Enterprise Center for $25,000
and other bank loans for $116,000.
Montana's CDBG-ED program is intended to promote
economic development by helping Montana's private
sector to create and retain jobs for low- and moderate-
income people.
The program receives funding from the CDBG
program funded by the U.S. Department of Housing
and Urban Development.
The REC will provide technical assistance, business
coaching, mentoring, advisory boards, networking
opportunities, access to capital programs, market
information and office space to local businesses.
The Economic Development Authority projects the
REC will create 253 jobs from the start up and
encourage more than $11 million in private
investment over the next 10 years.
About 60 percent of the REC facility will be leasable
space, or a maximum of 18 offices. When businesses
start with the REC program, they will lease those
spaces until they can sustain themselves.
____________________________
NIH Approves Master Plan for
Rocky Mountain Laboratories
The National Institutes of Health (NIH) has approved a
20-year Master Plan to guide the development of its
scientific research campus at Rocky Mountain
Laboratories in Hamilton. The approval comes after
three years of planning, consideration of public input
and the completion of an Environmental Impact
Statement.
The Master Plan option approved is the low-growth
proposal that NIH preferred in its draft document. That
option calls for RML employment to reach about 427
people by 2025; RML presently employs about 395
people, including government employees and
contractors.
Other options considered were no growth and
maximum capacity.
"Now we begin applying the plan to new activities on
the RML campus," said Ron Wilson, director of the
Division of Facilities Planning for the NIH. He will work
with NIH and RML personnel to plan initial activities,
but says likely high priorities include campus
landscaping, expansion of a security fence and
improvements to roads and parking.
Wilson said the Master Plan already has helped
prioritize one upcoming RML project, renovation of a
building that for many years housed the campus
boiler plant. That building will become a new biosafety
level-2 laboratory, with support and office space, in
RML's central building complex known as The Quad.
Formal approval of the Master Plan was announced in
a Record of Decision (ROD) published Tuesday in the
Federal Register. Copies of the ROD are available in
the RML Visitor's Center and on the Internet at
http://edocket.access.gpo.gov/2009/E9-10290.htm.
Along with some growth in personnel, the Master Plan
addresses the potential for land acquisition to the
north of RML's existing boundary and for limited
construction of new administrative and research
spaces.
All future construction and renovation projects must
first meet NIH's requirements for programmatic need
and must secure federal funding.
The ROD states that the Master Plan option
chosen "is intended to be a strategic tool for the
efficient allocation of campus resources, the orderly
accommodation of future growth and the creation of
an environment which is both functionally and
aesthetically conducive to accomplishing the RML
mission," which is scientific research. "New
development would be responsive to the context of
adjacent neighborhoods or developments."
The U.S. Department of Health and Human Services
(HHS), which oversees NIH, requires that all NIH
facilities have a Master Plan. RML is a component of
the NIH's National Institute of Allergy and Infectious
Diseases (NIAID), with headquarters in Bethesda,
MD.
Wilson is planning to travel to Hamilton from
Bethesda in June to discuss the Master Plan with
local government leaders, interested parties and RML
employees.
____________________________
11th Annual Montana
Neuroscience Retreat
By ANN MARIE QUINN
When most people think of Montana, they think of a
perfect day casting in the river, skiing in deep powder,
or hiking for beautiful views. It might come as a
surprise that Montana has become a first class place
for neuroscience too, as shown last weekend when
over 70 neuroscientists gathered for a retreat at
Seeley Lake. The 11th annual Montana Neuroscience
Retreat was a mecca for brain researchers across the
state, including attendees from the Center for
Structural and Functional Neuroscience at the
University of Montana, the McLaughlin Institute, the
Department of Cell Biology and Neuroscience at
Montana State University and representatives from
companies that develop products for brain research.
Dr. Matthew Ames, Director of Molecular
Pharmacology from the Mayo Clinic said, "They've
established a world-class neuroscience research
program in Montana. It's brought a whole new scope
of outstanding science to the universities in Montana,
and added to the economic climate."
The highlight of the meeting was the Saturday night
poster session. Awards were given for the best
posters. April Johnston, a Research Specialist and
recent graduate of MSU Cell Biology and
Neuroscience, was one of the award winners. "My
poster is about research I did while working in Charlie
Gray's lab at MSU, where I learned how to record
electrical activity in neurons. The techniques I learned
at MSU gave me the skills I needed to land my first job
as a scientist. I'm excited to be learning more
electrophysiology techniques to study the brain,
including patch clamping." April's new boss, Josh
Lawrence said, "I can't believe I was able to find a
person right out of college with April's skills. I am so
lucky to have April in the lab. She's already getting
some great results!" Drago Guggiana-Nilo, a Cell
Biology and Neuroscience student from MSU and
Alana White, a graduate student from University of
Montana also won awards for their posters. Winners
took home Apple ITouch prizes donated by Leeds
Instruments, a corporate sponsor of the annual
event.
The primary goals of the retreat are to bring Montana
neuroscientists together to share research results
and to foster collaborations that will advance
neuroscience research in the state. Mike Kavanaugh,
the University of Montana Director of Neuroscience
said, "I think scientists really love to share their data,
and when a discovery is made, that's almost what we
live for, to find something that is going to have an
impact on the field especially if it is something that
might potentially impact human health."
The meeting featured seminars on Saturday and
Sunday. Deb Cabin reported on the expansion at the
McLaughlin Institute, and plans to recruit new
neuroscientists. Thom Hughes, from MSU spoke
about the numerous biotech companies that impact
neuroscience research in Bozeman, including
Neuralynx, Gray Matter, Montana Molecular, Resonon,
AdVR and Fluorescence Innovations. He pointed out
the important role these companies play in providing
job opportunities for students graduating from the
University of Montana and MSU neuroscience
programs. Chris Comer, a neuroscientist and the
incoming Dean of Arts and Sciences at the University
of Montana, presented his work showing how
sensorimotor integration in the brain of naked mole
rats can provide clues about how to build the next
lunar explorer. Sensorimotor integration translates
sensory information in the brain into behavioral
responses, and can potentially inform the
development of new robotics for brain-operated
prosthetic devices too. Keynote addresses were given
by Jeffrey Rothstein from Johns Hopkins University
and Randy Blakely, the Allan D. Bass Professor of
Pharmacology and Psychiatry from Vanderbilt
University. Dr. Blakely talked about his recent
discoveries that provide new insights into the
molecular mechanisms of ADHD and the drugs used
to treat this disorder. Phil Beske, a graduate student at
the University of Montana who studies the underlying
effects of stroke on the brain, explained how the
enzyme NADPH oxidase plays a key role in learning
and memory and described his discovery that
overactivity of the enzyme, that occurs after a stroke,
can contribute to cell death.
Rain fell over the weekend but did not dampen the
enthusiasm for brain research or the camaraderie.
New ideas were hatched, collaborations were formed
and everyone left the meeting looking forward to the
next discovery and the opportunity to share it.

|
|
Industry News |
 |
Algal Biofuels Roadmap
Currently Under Construction
On December 9 and 10, 2008, the U.S. Department of
Energy (DOE), Office of Energy Efficiency and
Renewable Energy (EERE), Office of the Biomass
Program sponsored a technology roadmap workshop
to stimulate the development of commercial algal
biofuels. The workshop successfully brought together
the interdisciplinary expertise of more than 200
scientists, engineers, research managers, industry
representatives, academics, lawyers, financiers, and
regulators to fully discuss the promise and
challenges of a commercial algal biofuels industry.
Workshop participants insight was captured on a
range of technical challenges related to topics such
as:
· Algal Biology
· Cultivation
· Harvesting/Dewatering
· Extraction/Fractionation
· Conversion to Fuels
· Systems Integration
· Siting & Resources
· Regulation & Policy
In discussions throughout the workshop, industry,
academic, and national lab partners suggested that to
develop algal biofuels, the coordination and support of
fundamental research, infrastructure development,
technology deployment, and information management
at a national level by DOE will be necessary. A
complete workshop summary is now available at
www.orau.g
ov/algae2008pro and the results of
the workshop are being used to develop a technology
roadmap, which is expected to be published
Summer/Fall 2009.
________________________
NIAID and the Economic Recovery
Act
To spark a recovery of the U.S. economy,
Congress passed a $787 billion stimulus package.
President Barack Obama signed the American
Recovery and Reinvestment Act (ARRA) of 2009 into
law on February 17.
Congress and the President are looking to create and
save jobs, jump-start the economy, and build the
foundation for long-term economic growth.
The biomedical research enterprise has a major role
to play: NIH received an astounding 34 percent
increase to its budget in two-year stimulus funds, a
striking act of generosity and confidence on the part of
our elected leaders. Most of this money is slated to go
to universities and other research institutions around
the country.
The governments recognition of the importance of
biomedical and behavioral research will enable NAID
to uncover new knowledge that will improve public
health while moving the economy down the road to
recovery.
NIAID is responding to the challenge by awarding
hundreds of high-quality peer-reviewed grants so the
stimulus money can boost the economy quickly.
President Obama also emphasized the need for an
effective response, "What I will need from all of you is
unprecedented responsibility and accountability.
Follow the link below to read how NIH and NIAID
are meeting the President's challenge and find
important information for investigators.
NAID Economic Recovery Act

|
|
What's Happening? |
 |
Sharon Peterson participated in the 2009
Biotechnology Industry Organization Legislative Fly-In
on March 31 - April 1 2009. The Fly-in began with a
4:30 PM briefing on BIO's key legislative issues before
the U.S. Congress. Following the briefing, BIO hosted
a welcoming reception at 6:00 PM. The following
morning, Wednesday, April 1st began with an 8:00 AM
plenary breakfast on Capitol Hill. Russ Sullivan and
Kathy Koch from the Senate Finance Committee
spoke. Afterwards, participants were organized into
small groups for individual meetings with legislators
and key staff. The plenary luncheon featured Senator
Arlen Specter (R-Pennsylvania.)
________________________
Rob Bargatze, Sharon Peterson and Chuck
Richardson represented the Montana BioScience
Alliance at the 2009 BIO International Convention in
Atlanta Georgia, May 18-21. It was a busy convention
with almost 15,000 attendees. We had a 10 x 10
booth on the trade show floor and are very grateful to
the organizations who sent us material and to the
Governor's office for funding the booth. The three of
us were kept busy, attending Council of State
Bioscience Associations meetings, manning the
booth with a drawing for a custom made fly rod, and
attending the many meetings at the convention. A
couple of the highlights of the convention were the
keynote speech by Sir Elton John and a health care
policy keynote featuring Sen. Thomas Daschle (D-
SD): William Frist M.D. former Majority Leader of the
U.S. Senate: Gov. Howard Dean (D-VT): and Mr. Karl
Rove, Senior Advisor and Deputy Chief of Staff to
former President George W. Bush.
Next year's convention is well into the planning stages
and will be in Chicago May 3-6, 2010. Save the date
on your calendar and plan to join us.
________________________
HB 572 - Authorization for a SBIR/STTR matching
grant program for Montana was introduced in the
Montana House of Representatives by Rep. JP
Pomnichowski on February 20, 2009. After hearings in
the House and Senate Business and Labor
Committees, the bill passed both the House and
Senate and was signed by the Governor, April 15,
2009. Special thanks to Senator Kim Gillan for
requesting this vital legislation and carrying the bill in
the Senate, Rep. Pomnichowski for her strong support
and great work on the bill and Anne Marie Quinn for
representing the Alliance in this effort.
Included in HB 2 - the appropriations bill - is $2.5
million for bio-medical research. The Montana
Department of Commerce will be issuing grant
applications in the near future.

|
|
Events Calendar |
 |
June 26 and July 10, 2009
Pharmacy Open House
Prospective pre-pharmacy students or students who
will be applying for the professional pharmacy
program - You are invited to a Skaggs School of
Pharmacy open house.
Please call 406-243-4656 if you plan on attending an
open house. If you would also like to schedule a
campus tour, please call The University of Montana
Enrollment Services office at 406-243-6266.
July 8-9, 2009
Northwest Research and Education Institute Event
Certified HIPAA
Professional Training
Billings, MT
Call 406.237.5306
to Register
July 17, 2009
Montana BioScience Alliance Annual Meeting
Hamilton, MT
Register Here
July 23-24, 2009
Join us for the Rocky Mountain Valve Symposium
Aortic Dissection
August 14, 2009
McLaughlin Research Institute
Scientific Advisory Committee meeting and
Workshop
Heritage Hall, MSU-GF
September 10-11, 2009
Northwest Research and Education Institute Event
2nd Annual
Chiari Conference
Billings, MT
September 14-26, 2009
13th Annual
MT Regional
Sleep Seminar
Billings, MT
INFORMATION
&
REGISTRATION
September 16-18, 2009
Save the Date!
Western Region COBRE-INBRE Scientific Conference
Big Sky Resort Big Sky, Montana
(www.bigskyresort.com)
All Investigators, Staff, and Students are
welcome
Program details will be posted on the MT INBRE
website (http://inbre-brin.montana.edu) by late spring.
For more information or questions, please call or e-
mail Mark Quinn for COBRE (406-994-4707,
mquinn@montana.edu) or Ann Bertagnolli for INBRE
(406-994-5214 or
abertagnolli@montana.edu).

|
|
Classifieds |
 |
There is now a classifieds section on
the Montana Bio website, in the resources
section!
Please send information to Sharon at
sharonpeterson@bresnan.net .
Help Wanted
Summit Corporate Services, an outsource service
provider to the medical device industry, is seeking a
detail-oriented, upbeat, dependable individual to join
our team. This position is the Account Lead
responsible for bridging the gap between sales reps,
hospitals, and the device manufacturers, so
professional communication skills are essential.
Responsibilities will include: order processing and
fulfillment, inventory management, and Quality
Assurance document review. Individuals applying
should have excellent computer skills with attention to
detail and accuracy. Summit provides a relaxed but
productive work environment, great benefits, and
wages DOE. Please submit your resume in
confidence to HR@summitcorporate.com or fax to
(406) 556-1322.

|
|
|
 |
|
The Montana BioScience Alliance is located
on the Downtown Campus of Montana State
University-Billings, through the generous support of
the University.
|
| Quick Links... |
 |